Harriet de Wit
Directeur/Membre du Conseil chez PHARMALA BIOTECH HOLDINGS INC.
Fortune : 14 600 $ au 31/05/2024
Postes actifs de Harriet de Wit
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Membre du Conseil | 21/03/2021 | - |
| The University of Chicago | Corporate Officer/Principal | - | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Harriet de Wit
Formation de Harriet de Wit
| University of Calgary | Undergraduate Degree |
| Concordia University | Doctorate Degree |
Statistiques
Internationale
| Canada | 4 |
| 2 | |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| PharmAla Biotech Holdings, Inc. | |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Harriet de Wit
- Expérience
